Progress in Retinal and Eye Research

PROGRESS IN RETINAL AND EYE RESEARCH AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.3 ISSN: 1350-9462 DESCRIPTION . By invitation leading experts write on basic and clinical aspects of the eye in a style appealing to molecular biologists, neuroscientists and physiologists, as well as to vision researchers and ophthalmologists. The journal covers all aspects of eye research, including topics pertaining to the retina and pigment pithelial layer, cornea, tears, lacrimal glands, aqueous humour, iris, ciliary body, trabeculum, lens, vitreous humour and diseases such as dry-eye, inflammation, keratoconus, corneal dystrophy, glaucoma and cataract. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center Any queries with proposals for review articles can be sent directly to the Editor in Chief: Neville Osborne [email protected] AUDIENCE . Ophthalmologists and neuroscientists. IMPACT FACTOR . 2020: 21.198 © Clarivate Analytics Journal Citation Reports 2021 AUTHOR INFORMATION PACK 4 Oct 2021 www.elsevier.com/locate/preteyeres 1 ABSTRACTING AND INDEXING . PubMed/Medline Elsevier BIOBASE Ocular R Chemical Abstracts Embase Current Contents - Life Sciences Web of Science Research Alert Scopus EDITORIAL BOARD . Editor-in-Chief: Contact the Editor Neville Osborne, University of Oxford Nuffield Laboratory of Ophthalmology, Headley Way, OX3 9DU, Oxford, United Kingdom Advisory Board P. Campochiaro, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America A.D. Dick, Bristol Eye Hospital, Bristol, United Kingdom J-A. Sahel, Institute of Vision, Paris, France L. Schmetterer, Medical University of Vienna, Vienna, Austria V.Y. Arshavsky S. Bassnett, Washington University in St Louis School of Medicine, Saint Louis, Missouri, United States of America F. Behar-Cohen A.V. Ljubimov, CEDARS-SINAI MEDICAL CENTER, Los Angeles, California, United States of America M. Mochizuki K. Palczewski, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America D. Yu E. Zrenner J.B. Jonas J. Provis, Australian National University, Canberra, Australia T. Aung, Singapore National Eye Centre, Singapore, Singapore S. Schuman, New York University Grossman School of Medicine, New York, New York, United States of America A. Swaroop, National Eye Institute, Bethesda, Maryland, United States of America AUTHOR INFORMATION PACK 4 Oct 2021 www.elsevier.com/locate/preteyeres 2 GUIDE FOR AUTHORS . INTRODUCTION Articles are generally by invitation and written by leading experts with an appeal not only to ophthalmologists and vision researchers but also to those interested in molecular biology, neuroscience, physiology and genetics. The journal covers all aspects of research on the eye, including topics pertaining to the retina, pigment epithelial layer, cornea, tears, lacrimal glands, aqueous humour, iris, ciliary body, trabeculum, lens, vitreous humour and diseases such as dry-eye, inflammation, keratoconus, corneal dystrophy, glaucoma, diabetes, age-related macular degeneration and cataract. The primary aim of PRER is to highlight and focus on a particular research topic of current high interest. Articles are by definition extensive being at least 15 printed pages. Articles in PRER are generally overview-type articles concentrating on an area of the expertise of the author/authors. Articles might include important and new developments in a field, new theories and new views or twists on standard subjects which could point the way to further exciting research in the concluding "Future Directions" section of the article Articles can include unpublished data with appropriate necessary information. Authors are encouraged to discuss the subject matter in a manner that is not always possible in standard scientific publications, theorizing, philosophising and summarizing if necessary. It is to remembered, however, that the authors should highlight critical contributions from all laboratories, not only their own. Articles are, by definition, scholarly and authoritative yet "reader friendly". They should be accessible and understandable to investigators in other research areas. To achieve this, authors are encouraged to include appropriate diagrams, figures and cartoons. Cited references should be reasonable in number and selective. Contact details for submission Proposals to write a review should be sent to Professor Neville N. Osborne (Editor-in-Chief): Email: [email protected] Mail: Nuffield Laboratory of Ophthalmology, Oxford University,Level 6, West Wing,John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK Fax: +44 1865-234795. Submission checklist You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details. Ensure that the following items are present: One author has been designated as the corresponding author with contact details: • E-mail address • Full postal address All necessary files have been uploaded: Manuscript: • Include keywords • All figures (include relevant captions) • All tables (including titles, description, footnotes) • Ensure all figure and table citations in the text match the files provided • Please state % contribution made by each author in the preparation of this manuscript. • Indicate clearly if color should be used for any figures in print Graphical Abstracts / Highlights files (where applicable) Supplemental files (where applicable) Further considerations • Manuscript has been 'spell checked' and 'grammar checked' • All references mentioned in the Reference List are cited in the text, and vice versa • Permission has been obtained for use of copyrighted material from other sources (including the Internet) • A competing interests statement is provided, even if the authors have no competing interests to declare • Journal policies detailed in this guide have been reviewed AUTHOR INFORMATION PACK 4 Oct 2021 www.elsevier.com/locate/preteyeres 3 • Referee suggestions and contact details provided, based on journal requirements For further information, visit our Support Center. BEFORE YOU BEGIN Ethics in publishing Please see our information on Ethics in publishing. Other aspects of responsible conduct in publishing. All authors must to abide by the most current, relevant professional guidelines for responsible conduct in behavioral and biomedical publications. These include the following: The International Committee of Medical Journal Editors (http://www.icmje.org/index.html) (October 2007 version) The Society for Neuroscience (Society for Neuroscience (2000) J. Neurosci., 20, i-xiv. (http://web.sfn.org/content/AboutSfN1/Guidlines/guidelines.pdf) Declaration of interest All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information. Submission declaration and verification Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright- holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check. Preprints Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information). Use of inclusive language Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health

Load more